Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Hatteras Venture Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Hatteras Venture Partners

Hatteras Venture Partners

Operating

Hatteras Venture Partners: A US-based venture capital firm investing in healthcare and biopharmaceutical sectors.

Location
Durham, NC, US
Founded
2000
Firm
Compare
Portfolio
Employees
Website

Hatteras Venture Partners is a venture capital firm focused on early-stage investments in the healthcare and life sciences sectors. Based in the Research Triangle area, the firm primarily invests in biopharmaceuticals, medical devices, diagnostics, and healthcare-related companies. Hatteras typically participates in Seed, Series A, and Series B funding rounds, with occasional investments in later stages.

The firm's portfolio includes notable companies such as G1 Therapeutics, Kymera Therapeutics, and Shattuck Labs. Hatteras Venture Partners adds value to its portfolio companies through its deep industry expertise and connections in the life sciences ecosystem. The firm's partners bring extensive experience in healthcare and biotechnology, positioning Hatteras as a strategic investor for innovative startups in these sectors.

Hatteras Venture Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments78
Current Portfolio Count45
Total Portfolio Exits1

Top Investment Stages

Series A34 (45.3%)
Series B18 (24.0%)
Series Unknown10 (13.3%)
Seed8 (10.7%)
Series C5 (6.7%)

Stage Mix

Series A 45%Series B 24%Series Unknown 13%Seed 11%Series C 7%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Ladder Health logo

Ladder Health

Veralox Therapeutics logo

Veralox Therapeutics

410 Medical logo

410 Medical

Ten63 Therapeutics logo

Ten63 Therapeutics

Aer Therapeutics logo

Aer Therapeutics

Mercy BioAnalytics logo

Mercy BioAnalytics

Boomerang Medical logo

Boomerang Medical

Rapidpulse logo

Rapidpulse

Code Biotherapeutics logo

Code Biotherapeutics

Wildflower Health logo

Wildflower Health

Huma.AI logo

Huma.AI

Tune Therapeutics logo

Tune Therapeutics

Trefoil Therapeutics logo

Trefoil Therapeutics

GeneCentric Therapeutics logo

GeneCentric Therapeutics

GoCheck logo

GoCheck

Elligo Health Research logo

Elligo Health Research

Boston Immune Technologies & Therapeutics logo

Boston Immune Technologies & Therapeutics

StrideBio logo

StrideBio

Artizan Biosciences logo

Artizan Biosciences

Atsena Therapeutics logo

Atsena Therapeutics

Altis Biosystems logo

Altis Biosystems

Cvrx logo

Cvrx

Shattuck Labs logo

Shattuck Labs

AtaCor Medical logo

AtaCor Medical

Panaceutics Nutrition logo

Panaceutics Nutrition

Hatteras Venture Partners - Similar Investment Firms

Catalysta Ventures logo

Catalysta Ventures

H Venture Partners logo

H Venture Partners

h.ventures

Bioventures Investors logo

Bioventures Investors

Healthcare Ventures logo

Healthcare Ventures

hcven.com

Windham Venture Partners logo

Windham Venture Partners

windhamvp.com

Harbor Light Capital Partners logo

Harbor Light Capital Partners

hlcp.com

Atlas Venture logo

Atlas Venture

atlasventure.com

Boutique Venture Partners logo

Boutique Venture Partners

boutiquevc.com

Versant Ventures logo

Versant Ventures

Venture Investors logo

Venture Investors

Vertex Ventures HC logo

Vertex Ventures HC

Partner Ventures logo

Partner Ventures

partnervc.com

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

Latterell Venture Partners logo

Latterell Venture Partners

lvpcapital.com

Twilight Venture Partners logo

Twilight Venture Partners

Hatteras Venture Partners - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end